Today's stock picks by Teal Linde and Michael Sprung are RY-T, VET-T, T-T, BN-T, OWL-N, TRP-T.
It is riding three waves in the investment world: leaseback transactions, private credit and alternative investments. Also it owns stakes in private equity firms which are very profitable. Buy 10 Hold 4 Sell 0
(Analysts’ price target is $20.33)Its dividend is 7%. It is not usually that high which means the stock is oversold. It is putting out more positive news in the past little while and insiders have bought $8 million worth of stock over the past year. A lot of analysts have Hold positions and should start to move away from this. It beat earnings estimates by 20% and raised guidance. It is at the low end of its trading range. If interest rates come down then the price could rise. Buy 9 Hold 12 Sell 2
(Analysts’ price target is $55.92)Currently selling at premium to other banks in the market, but valuation is justified. RBC offers stability for investors in case markets fall. Very strong balance sheet and steady stream of earnings. Dividend ~4% is safe and reliable. Compliance issues behind company. Recent closing of HSBC Canada will generate profits going forward. Offers good value for long term investors.
Company has turned around - last quarter very strong. Believes energy prices will remain high. Company progressing in de-leveraging. Free cash flow will be returned to shareholders (~50%). Dividends are robust, and company on the way to recovery. Good valuation that offers safety for long term investors.
Recent weakness in valuation offers goof margin of safety for investors. Coming towards the end in fibre build out - will be good for cash flow. Various revenues steam good for stability of business. Company should be able to continue dividend increases (~7%). Current dividend yield is very safe.
A very contrarian pick. Why now? Company's pivoting from Covid to cancer. Unfortunately, cancer is a huge market with 1 in 3 being diagnosed. Very strong lineup of potential new blockbuster drugs, management confidence is high on them. Market underappreciates it. Estimated to grow earnings 14%. Trades at 10x, with nice yield of 5.96%.
Near the bottom, won't go much lower. Not if it will work, but when. You get a nice dividend. Tomorrow's winner.
Dead weight for a long time. Sweeping progress last year should continue and drive stock higher. Cheap, trades at 8x 2025 earnings, growing at 24%. More positive on US than Canadian banks. Pays decent dividend of 3.69%.
(Analysts’ price target is $61.92)Global leader in wealth management. Real estate appears to be turning the corner. If soft landing, one of his favourite plays. Fed rate cuts and rising liquidity should help shareholder returns. Trades at 10x price to adjusted funds, growing at 26%. Yield is 0.78%.
Ticks all boxes of offense and defense, growth and value. You don't have to sweat this name, a great performer all the time. Again, not if it goes higher, but when.
According to Teal Linde and Michael Sprung, the best stocks to buy today are RY-T, VET-T, T-T, BN-T, OWL-N, TRP-T.
It is the mother-ship corporation of all the other Brookfield entities. Its goal is to grow its capital at 15% compounded annually over the long term and has done this over the last 10 years and even more over the last 20 years. Its NAV is $74 per share as of last fall so it is trading at a discount to NAV. Buy 7 Hold 3 Sell 1
(Analysts’ price target is $64.43)